scispace - formally typeset
K

Kathryn Owens

Researcher at Cincinnati Children's Hospital Medical Center

Publications -  8
Citations -  492

Kathryn Owens is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Placenta & Fetus. The author has an hindex of 7, co-authored 8 publications receiving 325 citations.

Papers
More filters
Journal ArticleDOI

Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface.

TL;DR: This work studied the cell-cell interactome of fetal placental trophoblast cells and maternal endometrial stromal cells, using single-cell transcriptomics and finds a highly cell-type-specific expression of G-protein-coupled receptors, implying that ligand-receptor profiles could be a reliable tool for cell type identification.
Journal ArticleDOI

Hypoplastic left heart syndrome is associated with structural and vascular placental abnormalities and leptin dysregulation

TL;DR: Placentas from pregnancies complicated by fetal HLHS are characterized by abnormal parenchymal morphology, suggesting immature structure may be due to vascular abnormalities, and increased leptin expression may indicate an attempt to compensate for these vascular abnormalities.
Journal ArticleDOI

CXCR3 blockade protects against Listeria monocytogenes infection–induced fetal wastage

TL;DR: It is demonstrated that fetal wastage triggered by prenatal Listeria monocytogenes infection is driven by placental recruitment of CXCL9-producing inflammatory neutrophils and macrophages that promote infiltration of fetal-specific T cells into the decidua and suggested that therapeutically reinforcing this pathway represents a universal approach for mitigating immune-mediated pregnancy complications.
Journal ArticleDOI

Development of Non-Viral, Trophoblast-Specific Gene Delivery for Placental Therapy.

TL;DR: A nanostructure delivery system complexed with the IGF-1 gene to treat the placenta representing innovative building blocks towards human placental gene therapies is employed.
Journal ArticleDOI

Nanoparticle mediated increased insulin-like growth factor 1 expression enhances human placenta syncytium function.

TL;DR: The current study confirms that the nanoparticle is capable of uptake in human placental syncytium which results in enhanced transgene expression, functional changes to cellular activity and protection against increased oxidative stress.